Skip to main content
. 2023 Jan 30;12:1065716. doi: 10.3389/fonc.2022.1065716

Table 3.

Multivariate Cox analysis for OS in overweight patients.

Variable HR (univariable) HR (multivariable)
Age, y 1.05 (1.01-1.09, p=0.026) 1.07 (1.02-1.12, p=0.007)
Sex Female [Reference] [Reference]
Male 2.32 (0.71-7.63, p=0.164) 1.45 (0.34-6.16, p=0.614)
BMI, kg/m² 0.93 (0.77-1.12, p=0.451) 0.91 (0.73-1.12, p=0.372)
Tobacco Never [Reference] [Reference]
Former 0.85 (0.30-2.35, p=0.749) 0.88 (0.29-2.65, p=0.817)
Current 2.00 (0.94-4.27, p=0.072) 2.05 (0.88-4.78, p=0.097)
Tumor location Lower third [Reference] [Reference]
Middle thrid 3.34 (1.23-9.03, p=0.018) 3.67 (1.11-12.18, p=0.034)
Upper third 4.77 (1.85-12.33, p=0.001) 5.26 (1.62-17.14, p=0.006)
Tumor size, cm 1.29 (1.10-1.50, p=0.002) 1.12 (0.92-1.36, p=0.262)
Tumor grade Poorly differentiated [Reference] [Reference]
Well-moderately differentiated 0.56 (0.25-1.25, p=0.157) 0.77 (0.31-1.88, p=0.565)
TNM Stage I [Reference] [Reference]
II 2.69 (0.90-8.00, p=0.076) 2.20 (0.69-7.05, p=0.185)
III 6.74 (2.65-17.12, p<0.001) 6.23 (2.09-18.58, p=0.001)
IV 44.97 (8.75-231.03, p<0.001) 91.89 (11.62-726.88, p<0.001)
Postoperative complication No [Reference] [Reference]
Yes 1.60 (0.78-3.28, p=0.197) 1.56 (0.67-3.63, p=0.299)
Splenic volume < 185 ml [Reference] [Reference]
≥ 185 ml 2.80 (1.21-6.47, p=0.016) 3.55 (1.36-9.26, p=0.010)